Evidence map›Paper›PMID 20413507›Full record

ArticleDiabetes2010

The transcription factor Rfx3 regulates beta-cell differentiation, function, and glucokinase expression.

Aouatef Ait-Lounis, Claire Bonal, Queralt Seguín-Estévez, Christoph D Schmid, Philipp Bucher, Pedro L Herrera, Bénédicte Durand, Paolo Meda, Walter Reith

Abstract read
In one paragraph

Article in Diabetes, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Predictive control of human pancreatic cell fate using a digital model ofbioRxiv : the preprint server for biology · 2026
    Article
  3. Charting Endocrine Progenitors Across Species and Organs.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Centriolar Protein POC5 Regulates Human Adipogenesis and Cellular Senescence: Insights From a Novel Metabolic Ciliopathy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Multi-omic analysis of the ciliogenic transcription factorbioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aouatef Ait-LounisDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Centre Médical Universitaire, Geneva, Switzerland.
Claire Bonal
Queralt Seguín-Estévez
Christoph D Schmid
Philipp Bucher
Pedro L Herrera
Bénédicte Durand
Paolo Meda
Walter Reith

Funding

TRANSGENIC MODEL OF INDUCIBLE DIABETESU01DK072522 · NIDDK · UNIVERSITY OF GENEVA · PI HERRERA, PEDRO L · 2005 to 2009
$1.5M
NIDDK NIH HHS DK072522-01NIDDK NIH HHS U01 DK072522
6 · The paper itself

Abstract

objectivePancreatic islets of perinatal mice lacking the transcription factor Rfx3 exhibit a marked reduction in insulin-producing beta-cells. The objective of this work was to unravel the cellular and molecular mechanisms underlying this deficiency. RESEARCH DESIGN AND

methodsImmunofluorescence studies and quantitative RT-PCR experiments were used to study the emergence of insulin-positive cells, the expression of transcription factors implicated in the differentiation of beta-cells from endocrine progenitors, and the expression of mature beta-cell markers during development in Rfx3(-/-) and pancreas-specific Rfx3-knockout mice. RNA interference experiments were performed to document the consequences of downregulating Rfx3 expression in Min6 beta-cells. Quantitative chromatin immunoprecipitation (ChIP), ChIP sequencing, and bandshift experiments were used to identify Rfx3 target genes.

resultsReduced development of insulin-positive cells in Rfx3(-/-) mice was not due to deficiencies in endocrine progenitors or beta-lineage specification, but reflected the accumulation of insulin-positive beta-cell precursors and defective beta-cells exhibiting reduced insulin, Glut-2, and Gck expression. Similar incompletely differentiated beta-cells developed in pancreas-specific Rfx3-deficient embryos. Defective beta-cells lacking Glut-2 and Gck expression dominate in Rfx3-deficent adults, leading to glucose intolerance. Attenuated Glut-2 and glucokinase expression, and impaired glucose-stimulated insulin secretion, were also induced by RNA interference-mediated inhibition of Rfx3 expression in Min6 cells. Finally, Rfx3 was found to bind in Min6 cells and human islets to two well-known regulatory sequences, Pal-1 and Pal-2, in the neuroendocrine promoter of the glucokinase gene.

conclusionsOur results show that Rfx3 is required for the differentiation and function of mature beta-cells and regulates the beta-cell promoter of the glucokinase gene.

Indexed as

Analysis of VarianceAnimalsCell DifferentiationDNA-Binding ProteinsFluorescent Antibody TechniqueGlucokinaseInsulinInsulin-Secreting CellsIslets of LangerhansMiceMice, KnockoutPromoter Regions, GeneticRegulatory Factor X Transcription FactorsReverse Transcriptase Polymerase Chain ReactionRNA InterferenceTranscription FactorsDNA-Binding ProteinsGlucokinaseInsulinRegulatory Factor X Transcription FactorsRFX3 protein, humanRfx3 protein, mouseTranscription Factors

Identifiers

PMID20413507
PMCPMC2889767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.